Today i asked Jon if he could advise in relation to the Phelan-McDermid trial how many patients have completed the trial, how many are currently completing the trial and how many participants are required in each of the three age groups. Jon advised that none of that is public information and therefore he couldnt disclose however he did advise they "currently have patients in all three groups". I followed up with whether that meant the youngest group has commenced the trial- his reply "Yes, correct".
Thats great progress. I was expecting a read out in November but could be a couple months earlier.
Share Price, page-4807
-
- There are more pages in this discussion • 6,264 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.09 |
Change
0.000(0.00%) |
Mkt cap ! $2.184B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 555 | $17.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.00 | 1600 | 1 |
View Market Depth
| Last trade - 13.53pm 07/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |
Day chart unavailable